Effects of long-term use of tilmicosin premix on animal health and food safety
Publish Time: 2025-01-30
As a veterinary drug, tilmicosin premix is widely used to prevent and treat respiratory diseases in livestock and poultry, such as swine contagious pleuropneumonia and mycoplasma pneumonia. However, long-term use of tilmicosin premix may have a series of effects on animal health and food safety.
In terms of animal health, long-term use of tilmicosin premix may lead to increased drug resistance. This is because long-term exposure to antibiotics can cause bacteria to undergo genetic mutations, thereby developing drug resistance. Once bacteria develop resistance to tilmicosin, it will not only reduce the therapeutic effect of the drug, but may also lead to more serious infections. In addition, tilmicosin may also affect the balance of the intestinal flora of animals, leading to gastrointestinal discomfort symptoms such as diarrhea and abdominal pain. These symptoms not only affect the growth performance of animals, but may also reduce their immunity and increase the risk of disease.
In terms of food safety, long-term use of tilmicosin premix may lead to excessive drug residues. As an antibiotic, tilmicosin is usually not completely metabolized and excreted in animals, but accumulates in the body. When animals are slaughtered, these residual drugs may enter the food chain and pose a potential threat to human health. Long-term consumption of animal food containing tilmicosin residues may cause allergic reactions, cochlear nerve damage, hearing loss and other problems, and in severe cases may even cause serious damage to the liver and kidneys.
In order to ensure animal health and food safety, the use of tilmicosin premix should be strictly controlled. First, the advice of veterinarians should be followed to formulate a reasonable medication plan based on the animal's condition and medication history to avoid abuse and misuse. Secondly, the testing of animal products should be strengthened to ensure that the animal products sold on the market meet food safety standards. In addition, supervision of veterinary drug manufacturers should be strengthened to ensure that the veterinary drugs they produce meet relevant regulations and standards.
In short, long-term use of tilmicosin premix may have adverse effects on animal health and food safety. Therefore, the dosage and time of medication should be strictly controlled when using it, and testing and supervision should be strengthened to ensure animal health and human food safety. At the same time, it is also necessary to increase scientific research investment and develop safer and more effective veterinary drug alternatives to address the current problems of veterinary drug abuse and drug resistance.
